Skip to main content

Peer Review reports

From: The salvage therapy in lung adenocarcinoma initially harbored susceptible EGFR mutation and acquired resistance occurred to the first-line gefitinib and second-line cytotoxic chemotherapy

Original Submission
11 Dec 2016 Submitted Original manuscript
25 Dec 2016 Reviewed Reviewer Report - Tao Che
25 Dec 2016 Reviewed Reviewer Report - Niki Karachaliou
10 Jan 2017 Author responded Author comments - Chih-Jen Yang
Resubmission - Version 2
10 Jan 2017 Submitted Manuscript version 2
13 Jan 2017 Reviewed Reviewer Report - Niki Karachaliou
15 Jan 2017 Reviewed Reviewer Report - Tao Che
24 Jan 2017 Author responded Author comments - Chih-Jen Yang
Resubmission - Version 3
24 Jan 2017 Submitted Manuscript version 3
11 Feb 2017 Author responded Author comments - Chih-Jen Yang
Resubmission - Version 4
11 Feb 2017 Submitted Manuscript version 4
Publishing
28 Feb 2017 Editorially accepted
10 May 2017 Article published 10.1186/s40360-017-0130-0

You can find further information about peer review here.

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us